- FDA limits amount of acetaminophen in prescription drugs
- Study: Parents confident in administering correct acetaminophen dose with AccuDial dosing label
- FDA updates parents on acetaminophen guidance
- Bayer HealthCare brings OTC migraine relief to analgesic shelves
- Report: New Wash. law cuts off patient access to painkillers
PARSIPPANY, N.J. — Generic drug maker Watson Labs recalled two lots of a prescription painkiller due to the potential for oversized and overly potent tablets, the company said.
The drug maker announced the recall of hydrocodone bitartrate and acetaminophen tablets in the 10 mg/500 mg strengths based on a customer complaint of tablets that were thicker and darker-colored than the others.
The recalled lots are 519406A and 521759A, and the company said some tablets from the lots may exceed the weight specification and contain higher doses of hydrocodone or acetaminophen.